| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 May 2025 | 17 May 2025 |
| Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve To consider and approve the financial results for the period ended March 31 2025 Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025. (As per BSE Announcement Dated on 28/05/2025) | ||
| Board Meeting | 13 Feb 2025 | 3 Feb 2025 |
| ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve 1.The Standalone and Consolidated Unaudited Financial Results for the Quarter ended on 31st December 2024. 2.Appointment of Company Secretary and Compliance Officer of the Company. 3.Change in the Designation of Mr. Vitthal Kothana from Non- Executive Director to Executive Director. 4.Adoption of various Policies of the Company (as amended). Financial Results for the Quarter ended December, 2024 (As Per BSE Announcement Dated on: 13/02/2025) Change in designation of Mr. Vitthal Kothana (DIN- 09489318) from Non-Executive Director to Executive Director. (As Per BSE Announcement Dated on 14.02.2025) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Standalone and consolidated Financial results quarter and half yearly ended September2024. Financial Results for the quarter and half year ended 30th September,2024 (As Per Bse Announcement Dated on 14.11.2024) | ||
| Board Meeting | 13 Aug 2024 | 3 Aug 2024 |
| ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve financial results for the quarter ended June 2024. Financial Results for the quarter ended June,2024 (As Per Bse Announcement Dated on 13.08.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.